CRH Medical Corporation to Announce 2020 Third Quarter Results on November 12, 2020

Rhea-AI Summary

CRH Medical Corporation (TSX: CRH, NYSE MKT: CRHM) will release its Q3 2020 results on November 12, 2020, after market close. A conference call will be held on November 13, 2020, at 8:30 AM ET to discuss the results, accessible via phone at 1-888-664-6392 (toll-free). The company, focused on providing innovative services for gastrointestinal diseases, has grown significantly, serving 66 ambulatory surgical centers across 13 states and using its CRH O'Regan System for effective hemorrhoid treatment.

Positive

• CRH has completed 30 anesthesia acquisitions, expanding its service capacity.
• The company serves 66 ambulatory surgical centers across 13 states, indicating growth in its operational footprint.
• CRH's O'Regan System is utilized in all 48 lower US states, showcasing widespread adoption.

Negative

• None.

VANCOUVER, BC, Nov. 5, 2020 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) ("CRH" or the "Company"), plans to release its results for the quarter ended September 30, 2020, on Thursday, November 12, 2020 after market close.

The Company's executive management will discuss the results during a conference call on Friday, November 13, 2020 at 8:30 am Eastern Time/5:30 am Pacific Time. To participate in the call, please dial 1-888-664-6392 or 1-416-764-8659 and reference confirmation # 64836562.

An audio replay will be available shortly after the call by dialing 1-888-390-0541 or 1-416-764-8677 and entering access code 836562#. The replay will be available for two weeks after the call.

About CRH Medical Corporation:

CRH Medical Corporation is a North American company focused on providing gastroenterologists throughout the United States with innovative services and products for the treatment of gastrointestinal diseases. In 2014, CRH became a full-service gastroenterology anesthesia company that provides anesthesia services for patients undergoing endoscopic procedures in ambulatory surgical centers. To date, CRH has completed 30 anesthesia acquisitions, and now serves 66 ambulatory surgical centers in 13 states. In addition, CRH owns the CRH O'Regan System, a single-use, disposable, hemorrhoid banding technology that is safe and highly effective in treating all grades of hemorrhoids. CRH distributes the O'Regan System, treatment protocols, operational and marketing expertise as a complete, turnkey package directly to gastroenterology practices, creating meaningful relationships with the gastroenterologists it serves. CRH's O'Regan System is currently used in all 48 lower US states.

View original content:http://www.prnewswire.com/news-releases/crh-medical-corporation-to-announce-2020-third-quarter-results-on-november-12-2020-301165345.html

SOURCE CRH Medical Corporation

FAQ

When will CRH Medical Corporation announce its Q3 2020 results?

CRH Medical Corporation will announce its Q3 2020 results on November 12, 2020, after market close.

What time is the CRH Medical Corporation Q3 2020 results conference call?

The conference call discussing CRH Medical Corporation's Q3 2020 results will take place on November 13, 2020, at 8:30 AM ET.

How can I participate in the CRH Medical Corporation conference call?

To participate in the conference call, dial 1-888-664-6392 or 1-416-764-8659 and reference confirmation # 64836562.

What services does CRH Medical Corporation provide?

CRH Medical Corporation provides gastroenterologists with anesthesia services for endoscopic procedures and distributes the CRH O'Regan System for hemorrhoid treatment.